Innovating Works

PHX

Desconocido
AXREGEN: Axonal regeneration plasticity stem cells PHARMAXON SAS participó en un FP7: This is a multi-disciplinary training programme focussed on the experimental and clinical problems associated with axonal damage and repair...
Financiado
PLASTICISE: Promotion of plasticity as a treatment for neurodegenerative conditions PHARMAXON SAS participó en un FP7: Neurodegenerative diseases all cause damage to the circuitry of the nervous system, with loss of connections, axons and neurons. The loss ca...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.